Myeloma health economic model

Health economic model to establish the costs associated with different routes to presentation for patients with myeloma in the UK.

In partnership with Costello Medical, Myeloma UK developed an economic model that investigates the costs associated with delayed diagnosis (through different routes of presentation) for myeloma patients in the UK. Considerations include treatment costs, cost of complications and end of life care costs.

The model is designed to be user friendly and open access. We invite all those with new data to make use of the model and investigate some of the questions it may help answer. Please note that current limitation and data gaps are clearly identified.

The tutorial slide deck helps guide users in how to navigate the model. The model itself is presented as an Excel file with an accompanying full user guide. Finally, the interactive summary poster outlines some of the conclusions that can be drawn from the model and data currently available.

We hope that this model will be of interest to clinicians, researchers, policy stakeholders and others working in the field of myeloma presentation and diagnosis.